US FDA Emphasizes Timesavers In New eCopy Guidance
This article was originally published in Clinica
Executive Summary
The US FDA's device center wants PDFs submitted through the system to be formatted properly to prevent unnecessary delays when reviewers work with them. With this aim in mind, on Dec. 3, the Center for Devices and Radiological Health released an updated guidance (PDF) for industry on its electronic copy (eCopy) program for medical device submissions based on recommendations from Booz Allen Hamilton as part of the contractor's ongoing independent review of FDA's procedures.
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.